[HTML][HTML] Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study

A Shah, K Donovan, A McHugh, M Pandey, L Aaron… - Critical care, 2020 - Springer
Background Optimal prophylactic and therapeutic management of thromboembolic disease
in patients with COVID-19 remains a major challenge for clinicians. The aim of this study …

[HTML][HTML] Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study

M Fraissé, E Logre, O Pajot, H Mentec, G Plantefève… - Critical Care, 2020 - Springer
Methods We retrospectively analyzed data from patients admitted to our 41-bed COVID-19
ICU between March 6 and April 22, 2020. All patients received usual (prophylactic) or full …

[HTML][HTML] Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

JM Kruse, A Magomedov, A Kurreck, FH Münch… - Critical Care, 2020 - Springer
Background There is emerging evidence for enhanced blood coagulation in coronavirus
2019 (COVID-19) patients, with thromboembolic complications contributing to morbidity and …

[HTML][HTML] Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring

S Susen, CA Tacquard, A Godon, A Mansour… - Critical care, 2020 - Springer
COVID-19 is an infection induced by the SARS-CoV-2 coronavirus, and severe forms can
lead to acute respiratory distress syndrome (ARDS) requiring intensive care unit (ICU) …

[HTML][HTML] Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients

S Jonmarker, J Hollenberg, M Dahlberg, O Stackelberg… - Critical Care, 2020 - Springer
Background A substantial proportion of critically ill COVID-19 patients develop
thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis …

[HTML][HTML] Timing and causes of death in severe COVID-19 patients

C de Roquetaillade, S Bredin, JB Lascarrou… - Critical Care, 2021 - Springer
Background Previous studies reporting the causes of death in patients with severe COVID-
19 have provided conflicting results. The objective of this study was to describe the causes …

[HTML][HTML] Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study

N Buetti, A Tabah, A Loiodice, S Ruckly, AT Aslan… - Critical Care, 2022 - Springer
Background The study aimed to describe the epidemiology and outcomes of hospital-
acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically …

[HTML][HTML] Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients

M Remmelink, R De Mendonça, N D'Haene… - Critical care, 2020 - Springer
Background Post-mortem studies can provide important information for understanding new
diseases and small autopsy case series have already reported different findings in COVID …

Clinical determinants for fatality of 44,672 patients with COVID-19

G Deng, M Yin, X Chen, F Zeng - Critical Care, 2020 - Springer
Using meta-analysis to explore clinical determinants for death of COVID-19 patients has
been a problem due to insufficient sample size and overlapped cases [1]. In the study, we re …

[HTML][HTML] Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study

Y Yu, D Xu, S Fu, J Zhang, X Yang, L Xu, J Xu, Y Wu… - Critical care, 2020 - Springer
Background A COVID-19 outbreak started in Wuhan, China, last December and now has
become a global pandemic. The clinical information in caring of critically ill patients with …